Sharon Kehoe
ABK Biomedical raises $35 million USD to bring liver cancer treatment to market
kakameo
The Series D funding will support the commercialization of Halifax's Eye90 microspheres. Halifax-headquartered ABK Biomedical has raised US$35 million ...
